Cobimetinib
STUDY00019211
Phase 1 small_molecule active
Quick answer
Cobimetinib for Locally Advanced Pancreatic Ductal Adenocarcinoma is a Phase 1 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cardiff Oncology
- Indication
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active